Our Business Model

Operating under a comprehensive business model, SR Pharma (Sanitas Renova) specializes in:

Private Labeling: Partnering with global manufacturers to source and develop high-quality healthcare products, all marketed under the SR Pharma (Sanitas Renova) brand.
Agency Representation: Serving as an exclusive agent for select international manufacturers to facilitate market entry and expansion in Saudi Arabia.
Local Manufacturing: Introducing Active Pharmaceutical Ingredients (APIs) and establishing local production capabilities in Saudi Arabia to enhance self-sufficiency and promote the localization of pharmaceutical manufacturing.

Our commitment lies in integrating innovation, global healthcare standards, and local expertise to deliver world-class, pharmaceutical-grade treatments. Guided by Saudi Vision 2030, SR Pharma (Sanitas Renova) strives to elevate healthcare standards, create jobs, and contribute to sustainable development across the Kingdom.

Our Vision and Mission

Vision To lead the healthcare industry with transformative solutions by combining private labeling, local manufacturing, and strategic partnerships—starting with advanced wound care and gradually expanding into specialized healthcare products—while enhancing patient care and aligning with Saudi Vision 2030. Mission To empower healthcare providers and patients through innovative products and services that improve clinical outcomes, foster sustainable healthcare practices, and contribute to the overall advancement of the Kingdom’s healthcare system.

Core Values

• Innovation: We drive the future of healthcare through continuous creativity and evidence-based research.

• Excellence: We deliver unmatched quality in every product and service.

• Integrity: We uphold transparency and ethical business practices at all levels.

• Patient-Centered Care: We focus on solutions that enhance patient well-being and improve quality of life.

• Sustainability: We foster long term growth in harmony with societal and environmental needs.

Vision 2030 & The Kingdom

In line with Saudi Vision 2030, under the leadership of the Custodian of the Two Holy Mosques King Salman bin Abdulaziz Al Saud and Crown Prince Mohammed bin Salman Al Saud, SR Pharma (Sanitas Renova) is committed to:

Localizing Manufacturing: Reducing reliance on imports by elevating local production standards.
Enhancing Healthcare Infrastructure: Collaborating with government and private sectors to improve care accessibility.
Empowering Human Capital: Developing the skills of local talent in pharmaceutical sciences, R&D, and manufacturing.